These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 8915226)

  • 21. Influence of beclomethasone and salmeterol on the perception of methacholine-induced bronchoconstriction.
    Boulet LP; Turcotte H; Cartier A; Milot J; Côté J; Malo JL; Laviolette M
    Chest; 1998 Aug; 114(2):373-9. PubMed ID: 9726717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of regular salmeterol treatment on albuterol-induced bronchoprotection in mild asthma.
    Yates DH; Worsdell M; Barnes PJ
    Am J Respir Crit Care Med; 1997 Sep; 156(3 Pt 1):988-91. PubMed ID: 9310023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of salmeterol on nocturnal symptoms, airway function, and inflammation in asthma.
    Kraft M; Wenzel SE; Bettinger CM; Martin RJ
    Chest; 1997 May; 111(5):1249-54. PubMed ID: 9149578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute protection against exercise-induced bronchoconstriction by formoterol, salmeterol and terbutaline.
    Richter K; Janicki S; Jörres RA; Magnussen H
    Eur Respir J; 2002 May; 19(5):865-71. PubMed ID: 12030726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional antagonism with formoterol and salmeterol in asthmatic patients expressing the homozygous glycine-16 beta(2)-adrenoceptor polymorphism.
    Lipworth BJ; Dempsey OJ; Aziz I
    Chest; 2000 Aug; 118(2):321-8. PubMed ID: 10936119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tolerance to the protective effects of salmeterol on methacholine-induced bronchoconstriction: influence of inhaled corticosteroids.
    Boulet LP; Cartier A; Milot J; Côté J; Malo JL; Laviolette M
    Eur Respir J; 1998 May; 11(5):1091-7. PubMed ID: 9648961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolonged effect of inhaled salmeterol against exercise-induced bronchospasm.
    Kemp JP; Dockhorn RJ; Busse WW; Bleecker ER; Van As A
    Am J Respir Crit Care Med; 1994 Dec; 150(6 Pt 1):1612-5. PubMed ID: 7952623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bronchodilator subsensitivity to salbutamol after twice daily salmeterol in asthmatic patients.
    Grove A; Lipworth BJ
    Lancet; 1995 Jul; 346(8969):201-6. PubMed ID: 7616798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unaltered perception of dyspnoea during treatment with long-acting beta2-agonists.
    van der Woude HJ; Aalbers R
    Eur Respir J; 2001 Aug; 18(2):269-71. PubMed ID: 11529283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protection against allergen-induced asthma by salmeterol.
    Twentyman OP; Finnerty JP; Harris A; Palmer J; Holgate ST
    Lancet; 1990 Dec; 336(8727):1338-42. PubMed ID: 1978163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma.
    Cheung D; Timmers MC; Zwinderman AH; Bel EH; Dijkman JH; Sterk PJ
    N Engl J Med; 1992 Oct; 327(17):1198-203. PubMed ID: 1357550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bronchodilator and bronchoprotective effects of salmeterol in young patients with asthma.
    Simons FE; Soni NR; Watson WT; Becker AB
    J Allergy Clin Immunol; 1992 Nov; 90(5):840-6. PubMed ID: 1358932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Salmeterol in nocturnal asthma: a double blind, placebo controlled trial of a long acting inhaled beta 2 agonist.
    Fitzpatrick MF; Mackay T; Driver H; Douglas NJ
    BMJ; 1990 Dec; 301(6765):1365-8. PubMed ID: 1980220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Salmeterol improves quality of life in patients with asthma requiring inhaled corticosteroids. Salmeterol Quality of Life Study Group.
    Kemp JP; Cook DA; Incaudo GA; Corren J; Kalberg C; Emmett A; Cox FM; Rickard K
    J Allergy Clin Immunol; 1998 Feb; 101(2 Pt 1):188-95. PubMed ID: 9500751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of the effects of oral montelukast and inhaled salmeterol on response to rescue bronchodilation after challenge.
    Storms W; Chervinsky P; Ghannam AF; Bird S; Hustad CM; Edelman JM;
    Respir Med; 2004 Nov; 98(11):1051-62. PubMed ID: 15526805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential masking effects of salmeterol on airway inflammation in asthma.
    Mcivor RA; Pizzichini E; Turner MO; Hussack P; Hargreave FE; Sears MR
    Am J Respir Crit Care Med; 1998 Sep; 158(3):924-30. PubMed ID: 9731027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of a single dose of inhaled salmeterol on baseline airway caliber and methacholine-induced airway obstruction in asthmatic children.
    Verberne AA; Hop WC; Bos AB; Kerrebijn KF
    J Allergy Clin Immunol; 1993 Jan; 91(1 Pt 1):127-34. PubMed ID: 8093705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of long-term salmeterol treatment on exercise-induced asthma.
    Nelson JA; Strauss L; Skowronski M; Ciufo R; Novak R; McFadden ER
    N Engl J Med; 1998 Jul; 339(3):141-6. PubMed ID: 9664089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The cardiorespiratory response to submaximal exercise in subjects with asthma following pretreatment with controlled release oral salbutamol and high-dose inhaled salmeterol.
    Revill SM; Morgan MD
    Respir Med; 1998 Aug; 92(8):1053-8. PubMed ID: 9893775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Salmeterol xinafoate in asthmatic patients under consideration for maintenance oral corticosteroid therapy. UK Study Group.
    Boyd G
    Eur Respir J; 1995 Sep; 8(9):1494-8. PubMed ID: 8575574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.